Therapie in der Schwangerschaft

• Literatur

• 1 Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003; 42: 1287-1304
• 2 Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2004; 4: 473-492
• 3 Rothman KF, Pochi PE. Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol 1988; 19: 431-442
• 4 Nast A, Bayerl C, Borelli C et al. S2k-guideline for therapy of acne. JDDG 2010; 8 (Suppl. 02) S1-59
• 5 Bayerl C. Acne therapy in pregnancy. Hautarzt 2013; 64: 269-273
• 6 Cosmetic Ingredient Review Panel. Safety assessment of Salicylic acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Caproyl Salicylic Acid, Hexyldodcyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Athylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, and Tridecyl Salicylate. Int J Toxicol 2003; 22: 1-108
• 7 Sasseville D. Dermatological therapy during pregnancy and lactation. In: Harahap M, Wallach RC, eds. Skin Changes and Disease in Pregnancy. New York: Marcel Dekker; 1996: 249-319
• 8 Bayerl C, Degitz K, Meigel E, Kerscher M. Adjuvant dermato-cosmetic acne therapy. JDDG 2010; 1: S89-94